SCHEMBL42455

SCHEMBL42455

[CH2]C(Br)CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43151 0.91
SCHEMBL27907215 0.88 LCK (0.48)
SCHEMBL27978541 0.88 LCK (0.48)
SCHEMBL28280322 0.88 LCK (0.48)
SCHEMBL7863876 0.88 LCK (0.48)
SCHEMBL27907214 0.88 LCK (0.48)
SCHEMBL28982429 0.88 LCK (0.48)
SCHEMBL151988 0.88
SCHEMBL7872063 0.88 LCK (0.48)
SCHEMBL11323767 0.88 LCK (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107759621-A One kind contains bithiophene(And selenophen)Photoelectricity compound of modification and its production and use 国家纳米科学中心 2018-03-06 CN claimed
EP-4281072-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) VIFOR (INTERNATIONAL) AG (CH) 2023-11-29 EP disclosed
CN-116710091-A Membrane iron transporter inhibitors for the treatment of myelodysplastic syndrome (MDS) 威佛(国际)股份公司 2023-09-05 CN disclosed
CN-110785417-B Membrane iron transporter inhibitor salts 威佛(国际)股份公司 2023-05-23 CN disclosed
US-20220273634-A1 Ferroportin-Inhibitors For The Use In The Treatment Of Transfusion-Dependent Beta-Thalassemia (TDT) VIFOR (INTERNATIONAL) AG (CH) 2022-09-01 US disclosed
CN-114765955-A Methods and compositions for treating sickle cell disease with an iron transporter inhibitor (VIT-2763) 威佛(国际)股份公司 2022-07-19 CN disclosed
CN-114668761-A Novel ferroportin inhibitors 威佛(国际)股份公司 2022-06-28 CN disclosed
EP-3999060-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND TREATMENT OF KIDNEY INJURIES VIFOR (INTERNATIONAL) AG (CH) 2022-05-25 EP disclosed
EP-3999059-A1 FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) VIFOR (INTERNATIONAL) AG (CH) 2022-05-25 EP disclosed
CN-108290878-B Novel ferroportin inhibitors 威佛(国际)股份公司 2022-04-26 CN disclosed
US-5693396-A NEAR INFRARED LIGHT ABSORBERS MITSUI TOATSU CHEMICALS, INC. (JP) 1997-12-02 US disclosed
CN-1130377-A Cyclic amide derivatives OTSUKA PHARMA CO LTD (JP) 1996-09-04 CN disclosed
EP-0719258-A1 CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-07-03 EP disclosed
EP-0719839-A2 Phthalocyanine compounds and optical recording media comprising them MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-07-03 EP disclosed
WO-1996002508-A1 CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-02-01 WO disclosed
EP-0466096-A1 Derivatives of 4-hydroxyphenylsulfone JUJO PAPER CO., LTD. (JP) 1992-01-15 EP disclosed
US-4604210-A Method for removing cyclic phosphorus contaminants from organic substrates THE DOW CHEMICAL COMPANY (US) 1986-08-05 US disclosed
US-4460603-A 1-(2'-Haloalkyl)-amidomethyl-substituted acetanilide fungicides CHEVRON RESEARCH COMPANY (US) 1984-07-17 US disclosed
US-4156065-A 1-OXIDE, 1-SULFIDE, OR 1-HYDROCARBYLIMINO DERIVATIVE OF A PHOSPHOLENE, PHOSPHOLANE, OR PHOSPHETANE THE UPJOHN COMPANY (US) 1979-05-22 US disclosed
US-4010209-A Process THE UPJOHN COMPANY (US) 1977-03-01 US disclosed